Full text is available at the source.
Abstract
In a study of 577 participants, 87% reported difficulties accessing appropriate treatment for post-acute immune-mediated syndromes.
- Healthcare utilization was high among participants, yet significant access barriers remained.
- Major challenges included a lack of available therapies (60%) and not being taken seriously by medical personnel (26%).
- Perceived invalidation by healthcare providers was moderate across conditions: Long COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, and post-acute COVID-19 vaccination syndrome.
- Invalidation was especially pronounced in interactions with authorities and workplaces rather than solely within healthcare settings.
- Social media and online communities were crucial for information and support, particularly for individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Simplified